HSIC
Price
$70.57
Change
+$1.01 (+1.45%)
Updated
Jun 3 closing price
Capitalization
9.7B
62 days until earnings call
SNYR
Price
$2.07
Change
+$0.31 (+17.61%)
Updated
Jun 3 closing price
Capitalization
494.39K
Interact to see
Advertisement

HSIC vs SNYR

Header iconHSIC vs SNYR Comparison
Open Charts HSIC vs SNYRBanner chart's image
Henry Schein
Price$70.57
Change+$1.01 (+1.45%)
Volume$2.19M
Capitalization9.7B
Synergy CHC
Price$2.07
Change+$0.31 (+17.61%)
Volume$218.94K
Capitalization494.39K
HSIC vs SNYR Comparison Chart
Loading...
HSIC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNYR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HSIC vs. SNYR commentary
Jun 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HSIC is a Buy and SNYR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 04, 2025
Stock price -- (HSIC: $70.57 vs. SNYR: $2.07)
Brand notoriety: HSIC and SNYR are both not notable
Both companies represent the Medical Distributors industry
Current volume relative to the 65-day Moving Average: HSIC: 142% vs. SNYR: 14%
Market capitalization -- HSIC: $9.7B vs. SNYR: $494.39K
HSIC [@Medical Distributors] is valued at $9.7B. SNYR’s [@Medical Distributors] market capitalization is $494.39K. The market cap for tickers in the [@Medical Distributors] industry ranges from $70.55B to $0. The average market capitalization across the [@Medical Distributors] industry is $10.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HSIC’s FA Score shows that 0 FA rating(s) are green whileSNYR’s FA Score has 0 green FA rating(s).

  • HSIC’s FA Score: 0 green, 5 red.
  • SNYR’s FA Score: 0 green, 5 red.
According to our system of comparison, SNYR is a better buy in the long-term than HSIC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HSIC’s TA Score shows that 5 TA indicator(s) are bullish while SNYR’s TA Score has 2 bullish TA indicator(s).

  • HSIC’s TA Score: 5 bullish, 5 bearish.
  • SNYR’s TA Score: 2 bullish, 4 bearish.
According to our system of comparison, HSIC is a better buy in the short-term than SNYR.

Price Growth

HSIC (@Medical Distributors) experienced а -4.19% price change this week, while SNYR (@Medical Distributors) price change was +16.29% for the same time period.

The average weekly price growth across all stocks in the @Medical Distributors industry was -1.95%. For the same industry, the average monthly price growth was -0.63%, and the average quarterly price growth was -4.99%.

Reported Earning Dates

HSIC is expected to report earnings on Aug 05, 2025.

SNYR is expected to report earnings on Mar 31, 2025.

Industries' Descriptions

@Medical Distributors (-1.95% weekly)

Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HSIC($9.71B) has a higher market cap than SNYR($494K). HSIC YTD gains are higher at: 1.980 vs. SNYR (-52.955). HSIC has higher annual earnings (EBITDA): 877M vs. SNYR (-8.26M). HSIC has more cash in the bank: 171M vs. SNYR (315K). SNYR has less debt than HSIC: SNYR (5.8M) vs HSIC (2.74B). HSIC has higher revenues than SNYR: HSIC (12.3B) vs SNYR (26M).
HSICSNYRHSIC / SNYR
Capitalization9.71B494K1,964,575%
EBITDA877M-8.26M-10,621%
Gain YTD1.980-52.955-4%
P/E Ratio23.50N/A-
Revenue12.3B26M47,308%
Total Cash171M315K54,286%
Total Debt2.74B5.8M47,259%
FUNDAMENTALS RATINGS
HSIC vs SNYR: Fundamental Ratings
HSIC
SNYR
OUTLOOK RATING
1..100
972
VALUATION
overvalued / fair valued / undervalued
1..100
78
Overvalued
56
Fair valued
PROFIT vs RISK RATING
1..100
5885
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
5334
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SNYR's Valuation (56) in the null industry is in the same range as HSIC (78) in the Medical Distributors industry. This means that SNYR’s stock grew similarly to HSIC’s over the last 12 months.

HSIC's Profit vs Risk Rating (58) in the Medical Distributors industry is in the same range as SNYR (85) in the null industry. This means that HSIC’s stock grew similarly to SNYR’s over the last 12 months.

HSIC's SMR Rating (100) in the Medical Distributors industry is in the same range as SNYR (100) in the null industry. This means that HSIC’s stock grew similarly to SNYR’s over the last 12 months.

SNYR's Price Growth Rating (34) in the null industry is in the same range as HSIC (53) in the Medical Distributors industry. This means that SNYR’s stock grew similarly to HSIC’s over the last 12 months.

SNYR's P/E Growth Rating (100) in the null industry is in the same range as HSIC (100) in the Medical Distributors industry. This means that SNYR’s stock grew similarly to HSIC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
HSICSNYR
RSI
ODDS (%)
Bearish Trend 2 days ago
68%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
57%
Bullish Trend 2 days ago
78%
Momentum
ODDS (%)
Bearish Trend 2 days ago
58%
Bearish Trend 2 days ago
74%
MACD
ODDS (%)
Bearish Trend 2 days ago
64%
Bearish Trend 2 days ago
54%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
57%
Bearish Trend 2 days ago
74%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
47%
Bearish Trend 2 days ago
64%
Advances
ODDS (%)
Bullish Trend 19 days ago
54%
Bullish Trend 19 days ago
70%
Declines
ODDS (%)
Bearish Trend 2 days ago
56%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
66%
Bearish Trend 2 days ago
71%
Aroon
ODDS (%)
Bullish Trend 2 days ago
45%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
HSIC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNYR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FDECX21.61N/A
N/A
Fidelity Advisor Capital Development C
FGEAX25.24N/A
N/A
Fidelity Advisor Glbl Capital Apprec A
CAFRX9.23N/A
N/A
Commonwealth Africa
PHLQX40.92N/A
N/A
PGIM Jennison Health Sciences R6
SIVIX16.14N/A
N/A
State Street Instl Small-Cap Equity Inv

HSIC and

Correlation & Price change

A.I.dvisor tells us that HSIC and ZYXI have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HSIC and ZYXI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HSIC
1D Price
Change %
HSIC100%
+1.45%
ZYXI - HSIC
26%
Poorly correlated
+5.94%
CAH - HSIC
20%
Poorly correlated
+0.15%
OMI - HSIC
19%
Poorly correlated
+5.35%
COR - HSIC
18%
Poorly correlated
-0.18%
SHTDY - HSIC
11%
Poorly correlated
-0.04%
More

SNYR and

Correlation & Price change

A.I.dvisor tells us that SNYR and COSM have been poorly correlated (+17% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SNYR and COSM's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNYR
1D Price
Change %
SNYR100%
+17.61%
COSM - SNYR
17%
Poorly correlated
-0.22%
ZYXI - SNYR
-1%
Poorly correlated
+5.94%
CAH - SNYR
-3%
Poorly correlated
+0.15%
HSIC - SNYR
-7%
Poorly correlated
+1.45%
MCK - SNYR
-7%
Poorly correlated
-0.95%
More